BUY Eris Lifesciences Limited — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))13 Nov 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·14 Nov · today
Nothing found in this tip’s window yet.
RSI at 85 — overbought territory
Technicals · rsi·14 Nov · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eris Lifesciences
- BUY — Prabhudas Lilladher27 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY — Pawan Maheshwari8 Sept 2026 · ~2 weeks · target ₹1,360 · Target hit
- BUY — Sandeep Jain, Tradeswift7 Sept 2026 · ~2 weeks · target ₹1,430 · Expired
- BUY — Elara Capital28 Aug 2026 · ~1 year · target ₹1,471 · Active
- BUY — HDFC Securities29 Jul 2026 · ~1 year · target ₹1,730 · Active
More from Madhu Bansal
- BUY Nazara Technologies13 Nov 2026 · ~2 weeks · target ₹467 · Active
- BUY Signatureglobal (India)12 Nov 2026 · ~2 weeks · target ₹835 · Active
- BUY Shilpa Medicare12 Nov 2026 · ~2 weeks · target ₹1,050 · Active
- BUY Supriya Lifescience11 Nov 2026 · ~2 weeks · target ₹725 · SL hit
- BUY Rashtriya Chemicals and Fertilizers11 Nov 2026 · ~2 weeks · target ₹116 · Active

